217 related articles for article (PubMed ID: 28423584)
1. Hepatocyte growth factor is a prognostic marker in patients with colorectal cancer: a meta-analysis.
Huang CY; Zhou QY; Hu Y; Wen Y; Qiu ZW; Liang MG; Mo JL; Xu JH; Sun C; Liu FB; Chen XL
Oncotarget; 2017 Apr; 8(14):23459-23469. PubMed ID: 28423584
[TBL] [Abstract][Full Text] [Related]
2. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis.
Chen XL; Chen ZQ; Zhu SL; Liu TW; Wen Y; Su YS; Xi XJ; Hu Y; Lian L; Liu FB
BMC Cancer; 2017 Apr; 17(1):240. PubMed ID: 28376764
[TBL] [Abstract][Full Text] [Related]
4. Elevated tumor-to-liver uptake ratio (TLR) from
Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
[TBL] [Abstract][Full Text] [Related]
5. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.
Wang EL; Qian ZR; Nakasono M; Tanahashi T; Yoshimoto K; Bando Y; Kudo E; Shimada M; Sano T
Br J Cancer; 2010 Mar; 102(5):908-15. PubMed ID: 20145615
[TBL] [Abstract][Full Text] [Related]
6. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
[TBL] [Abstract][Full Text] [Related]
7. Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis.
Wang B; Li F; Zhou X; Ma Y; Fu W
World J Surg Oncol; 2019 Oct; 17(1):169. PubMed ID: 31639018
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of NRAS Gene for Survival of Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Hu Y; Tao SY; Deng JM; Hou ZK; Liang JQ; Huang QG; Li LH; Li HB; Chen YM; Yi H; Chen XL; Liu H
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3001-3008. PubMed ID: 30484984
[TBL] [Abstract][Full Text] [Related]
9. Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer.
Sotelo MJ; Sastre J; Maestro ML; Veganzones S; Viéitez JM; Alonso V; Grávalos C; Escudero P; Vera R; Aranda E; García-Alfonso P; Gallego-Plazas J; Lopez C; Pericay C; Arrivi A; Vicente P; Ballesteros P; Elez E; López-Ladrón A; Díaz-Rubio E
Ann Oncol; 2015 Mar; 26(3):535-41. PubMed ID: 25515656
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between the expression of DDX39 protein and prognosis of colorectal cancer].
Ma J; Chang W; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar; 21(3):336-341. PubMed ID: 29577224
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis.
Liu Y; Tang W; Wang J; Xie L; Li T; He Y; Qin X; Li S
Diagn Pathol; 2013 Nov; 8():181. PubMed ID: 24188373
[TBL] [Abstract][Full Text] [Related]
12. Impact of sidedness of colorectal cancer on tumor immunity.
Takasu C; Nishi M; Yoshikawa K; Tokunaga T; Kashihara H; Yoshimoto T; Shimada M
PLoS One; 2020; 15(10):e0240408. PubMed ID: 33045001
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China.
Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
Int J Surg; 2018 Aug; 56():188-194. PubMed ID: 29936197
[TBL] [Abstract][Full Text] [Related]
14. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
[TBL] [Abstract][Full Text] [Related]
15. Log odds of positive lymph nodes as a novel prognostic predictor for colorectal cancer: a systematic review and meta-analysis.
Li Y; Wu G; Zhang Y; Han B; Yang W; Wang X; Duan L; Niu L; Chen J; Zhou W; Liu J; Fan D; Hong L
BMC Cancer; 2022 Mar; 22(1):290. PubMed ID: 35303818
[TBL] [Abstract][Full Text] [Related]
16. Prognostic stratification of patients with pT4bN0M0 colorectal cancer following multivisceral resection: a multi-institutional case series analysis.
Quan J; Zuo K; Li G; Liu J; Mei S; Hu G; Qiu W; Zhuang M; Meng L; Wang X; Chang H; Tang J
Int J Surg; 2024 May; ():. PubMed ID: 38768462
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M
PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310
[TBL] [Abstract][Full Text] [Related]
18. Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
Gaber A; Nodin B; Hotakainen K; Nilsson E; Stenman UH; Bjartell A; Birgisson H; Jirström K
BMC Cancer; 2010 Sep; 10():498. PubMed ID: 20849596
[TBL] [Abstract][Full Text] [Related]
19. Association Between Hypoxia-Inducible Factor-2α (HIF-2α) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis.
Han S; Huang T; Li W; Liu S; Yang W; Shi Q; Li H; Ren J; Hou F
Cell Physiol Biochem; 2018; 48(2):516-527. PubMed ID: 30021192
[TBL] [Abstract][Full Text] [Related]
20. Twist2 is a valuable prognostic biomarker for colorectal cancer.
Yu H; Jin GZ; Liu K; Dong H; Yu H; Duan JC; Li Z; Dong W; Cong WM; Yang JH
World J Gastroenterol; 2013 Apr; 19(15):2404-11. PubMed ID: 23613636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]